NORTHWEST BIOSOLIDS (EIN 911609567) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1994

Legal Domicile

Principal Officer

JAMES DUNBAR

Phone

2064710460

Tax Period

2023-01-01 to 2023-12-31

NORTHWEST BIOSOLIDS, founded in 1994, is a small nonprofit that reported $631K in total revenue in fiscal year 2023. Revenue surged 36% from the prior year, signaling strong growth momentum. Expenses of $541K left a modest 14% surplus.

Mission

TO FIND THE BENEFICIAL USES OF BIOSOLIDS AND SAFE WAYS TO MANAGE IT REGIONALLY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $613,269

Investment Income $4

Other Revenue $17,652

TOTAL REVENUE $630,925

Expense Breakdown

Grants Paid $112,303

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $428,760

TOTAL EXPENSES $541,063

Year-over-Year Comparison

	2023	2022	Change
Revenue	$630,925	$464,551	+0.4%
Expenses	$541,063	$217,435	+1.5%
Net Income	$89,862	$247,116	-0.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JAMES DUNBAR	PRESIDENT	8.00	Officer Director	$0	$0	$0
DARRELL WINANS	VICE-PRESIDENT	1.00	Officer Director	$0	$0	$0
BEN NYDEGGER	SECRETARY	1.00	Officer Director	$0	$0	$0
TERRI PRATHER	TREASURER	1.00	Officer Director	$0	$0	$0
TANIA GHESEGAR	PAST PRESIDENT	5.00	Director	$0	$0	$0
DEIDRE BARTLETT	DIRECTOR	1.00	Director	$0	$0	$0
CAT GOWAN	DIRECTOR	2.00	Director	$0	$0	$0
KARLA GUEVARRA	DIRECTOR	1.00	Director	$0	$0	$0
MACLEOD PAPPIDAS	DIRECTOR	2.00	Director	$0	$0	$0
JR INMAN	DIRECTOR	1.00	Director	$0	$0	$0
MIKE VAN HAM	DIRECTOR	1.00	Director	$0	$0	$0
MIKE GATES	DIRECTOR	1.00	Director	$0	$0	$0
REBECCA SINGER	DIRECTOR	1.00	Director	$0	$0	$0
KASIE AUGER	DIRECTOR	1.00	Director	$0	$0	$0
AMY OHLINGER	EXECUTIVE DIRECTOR	40.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$630,925	$541,063	$561,609	$89,862
2022	$469,249	$401,498	$557,576	$67,751
2022	$464,551	$217,435	$753,068	$247,116
2021	$336,051	$258,354	$544,823	$77,697
2019	$496,504	$541,638	$462,995	$-45,134
2018	$436,320	$345,594	$461,113	$90,726

NORTHWEST BIOSOLIDS